These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7855557)

  • 1. Epidemiology of toxic shock syndrome toxin-1 production in Staphylococcus aureus strains isolated in Denmark between 1959 and 1990.
    Ejlertsen T; Jensen A; Lester A; Rosdahl VT
    Scand J Infect Dis; 1994; 26(5):599-604. PubMed ID: 7855557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.
    Marples RR; Wieneke AA
    Epidemiol Infect; 1993 Jun; 110(3):477-88. PubMed ID: 8519313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.
    Igarashi H; Fujikawa H; Shingaki M; Bergdoll MS
    J Clin Microbiol; 1986 Mar; 23(3):509-12. PubMed ID: 3082921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.
    Dickgiesser N; Brombacher A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
    Bonventre PF; Weckbach L; Harth G; Haidaris C
    Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad.
    Adesiyun AA; Singh D; Gunness RI
    Zentralbl Bakteriol; 1994 Jan; 280(3):371-81. PubMed ID: 8167431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic shock syndrome in Britain--epidemiology and microbiology.
    de Saxe MJ; Hawtin P; Wieneke AA
    Postgrad Med J; 1985; 61 Suppl 1():5-21. PubMed ID: 4059160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
    Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
    Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
    Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
    Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
    Dickgiesser N; Brombacher A; Wiest W
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of virulence factors produced by MRSA strains isolated from blood samples].
    Mizukane R; Nakatomi M; Futsuki Y; Araki J; Asai S; Sawatari K; Hirakata Y; Maesaki S; Tomono K; Kohno S
    Kansenshogaku Zasshi; 1998 Aug; 72(8):788-93. PubMed ID: 9780580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal violet binding, cell surface properties and extracellular enzyme profiles of Staphylococcus aureus producing toxic shock syndrome toxin-1.
    Naidu AS; Jimenez J; Rollof J; Aleljung P; Nilsson-Ehle P; Larsson L; Hedström SA
    Zentralbl Bakteriol; 1989 May; 271(1):11-21. PubMed ID: 2669786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1.
    Reeves MW
    Rev Infect Dis; 1989; 11 Suppl 1():S145-49; discussion S149-50. PubMed ID: 2928630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.
    Laabei M; Young A; Jenkins TA
    Pediatr Infect Dis J; 2012 May; 31(5):e73-7. PubMed ID: 22301473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
    Parsonnet J; Gillis ZA; Pier GB
    J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal community state types (CSTs) alter environmental cues and production of the
    Maduta CS; McCormick JK; Dufresne K
    J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.